---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-085198"
form_type: "8-K"
ticker: "NWBO"
cik: "0001072379"
company_name: "NORTHWEST BIOTHERAPEUTICS INC"
filed_at: "2024-08-02T23:59:59+00:00"
generated_at: "2026-05-31T13:21:52.315722+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "medium"
source: SEC EDGAR
---

# NW Bio investigates social media rumors; MHRA MAA review continues

## Summary
- Company probing rumors linked to parties in federal NY lawsuit; coinciding with stock market developments.
- Plans to pursue appropriate action against rumor sources; shareholders asked to report information.
- MHRA review of Marketing Authorization Application in UK ongoing; inspections scheduled in US and UK.
- CEO Linda Powers signed the disclosure; no financial guidance or earnings data provided.

## SEC filing metadata
- accession: 0001104659-24-085198
- form_type: 8-K
- ticker: NWBO
- cik: 0001072379
- company_name: NORTHWEST BIOTHERAPEUTICS INC
- filed_at: 2024-08-02T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: medium
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1072379/000110465924085198/0001104659-24-085198-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1072379/000110465924085198/tm2420750d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-085198
- JSON: https://secwatch.observer/filing/0001104659-24-085198.json
- Plain text: https://secwatch.observer/filing/0001104659-24-085198.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.